Litcius/Paper detail

Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors

Julian A. Waksal, John Mascarenhas

2022Current Hematologic Malignancy Reports11 citationsDOI

Topics & Concepts

MedicineRuxolitinibMyelofibrosisClinical trialMyeloproliferative neoplasmExtramedullary hematopoiesisOncologyInternal medicineBone marrowStem cellImmunologyHaematopoiesisBiologyGeneticsMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia Treatments
Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors | Litcius